Galera Therapeutics Inc. (GRTX)

OTC: GRTX · Real-Time Price · USD

0.03

0.00 (9.09%)

At close: Apr 04, 2025, 2:24 PM

Galera Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Net Income	-18.96M	-59.08M	-62.22M	-80.53M	-74.22M	-51.93M	-23.68M	-23.55M
Depreciation & Amortization	20K	259K	114K	778K	368K	267K	127K	84K
Stock-Based Compensation	2.54M	5.56M	7.16M	7.23M	5.54M	2.39M	865K	726K
Other Working Capital	n/a	-721K	1.48M	-2.53M	2.71M	-732K	-1.29M	-19K
Other Non-Cash Items	n/a	11.34M	11.57M	7.19M	4.88M	3.04M	220K	1.61M
Deferred Income Tax	-203K	n/a	-70K	n/a	-16K	232K	n/a	n/a
Change in Working Capital	n/a	-2.93M	17K	-2.63M	3.91M	-655K	298K	-671K
Operating Cash Flow	n/a	-44.85M	-43.43M	-67.96M	-59.54M	-46.66M	-22.17M	-23.41M
Capital Expenditures	n/a	-59K	-25K	-283K	-457K	-633K	-347K	-319K
Cash Acquisitions	n/a	n/a	-24.02K	-5.52K	-37K	27.19K	n/a	n/a
Purchase of Investments	n/a	-22.64M	-59.89M	-71.98M	-67.75M	-123.19M	-71.19M	-9.92M
Sales Maturities Of Investments	n/a	49.99M	83.91M	77.5M	104.75M	96M	12.5M	33.75M
Other Investing Acitivies	-46K	n/a	24.02K	5.52K	37K	-27.19K	-58.69M	23.83M
Investing Cash Flow	-46K	27.29M	23.99M	5.24M	36.55M	-27.82M	-59.04M	23.51M
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	2.22M	2.2M	81K	58.77M	20.51M	20.01M	20M	n/a
Financial Cash Flow	2.22M	31.5M	3.89M	66.71M	20.51M	78.03M	89.84M	n/a
Net Cash Flow	-9.97M	13.94M	-15.54M	3.99M	-2.48M	3.54M	8.64M	106K
Free Cash Flow	n/a	-44.91M	-43.45M	-68.24M	-59.99M	-47.29M	-22.51M	-23.73M